Skip to main content
. 2020 Jul 2;51(8):2322–2331. doi: 10.1161/STROKEAHA.119.028396

Table 2.

Outcomes Among Patients Who Received Alteplase for AIS in the Full SITS-UTMOST Registry Population and Age-Defined Subgroups Who Met European Regulatory Criteria*

graphic file with name str-51-2322-g004.jpg